All In MedTech

FDA Clearance Tracker · P970003-S241

VNS Therapy System; Model 3100 Programming Software; Model 2000 Programming Wand

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 15, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 15, 2023

Approved

Time to decision

165 days

Received Apr 3, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970003-S241
Device name
VNS Therapy System; Model 3100 Programming Software; Model 2000 Programming Wand
Applicant location
Houston, TX
Received
Apr 3, 2023
Decided
Sep 15, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P970003

Device type

Device class
Class III

Every decision under product code LYJ

FDA's approval statement

As written in FDA's record.

Approval for the new Model 3100 v1.0 Programmer Software, updated M2000 v1.1.2.2 Programming Wand Firmware, and the new Digital Products Platform.

Source documents

Other decisions for LivaNova USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.